Feb 21 (Reuters) - Proteomics International Laboratories Ltd (PIQ) :
- GRANTED A PATENT IN UNITED STATES FOR USE OF ONE OF CORE PROMARKERD BIOMARKERS AS A POTENTIAL DRUG TARGET
Source text (http//reut.rs/2SPRdVP)
(([email protected];))
- Forums
- ASX - By Stock
- PIQ
- News: PIQ Proteomics International Laboratories Granted Patent In U.S. For Use Of One Of Core...
News: PIQ Proteomics International Laboratories Granted Patent In U.S. For Use Of One Of Core...
Add PIQ (ASX) to my watchlist
(20min delay)
|
|||||
Last
70.5¢ |
Change
0.010(1.44%) |
Mkt cap ! $85.15M |
Open | High | Low | Value | Volume |
71.0¢ | 71.0¢ | 69.0¢ | $10.51K | 14.9K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 101449 | 69.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
71.0¢ | 10000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 7843 | 0.700 |
2 | 8476 | 0.695 |
1 | 15000 | 0.685 |
4 | 12116 | 0.680 |
1 | 12500 | 0.675 |
Price($) | Vol. | No. |
---|---|---|
0.720 | 20000 | 1 |
0.735 | 623 | 1 |
0.740 | 5000 | 1 |
0.760 | 10000 | 1 |
0.770 | 7076 | 2 |
Last trade - 12.53pm 15/11/2024 (20 minute delay) ? |
PIQ (ASX) Chart |